Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma
Clinical trial NCT00068211 · COMPLETED
Trial details
- NCT number
- NCT00068211
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.